Page 153 - Case Lab Case Analysis
P. 153
Congress, or $166 per two-pack. A potential overcharging of
the government by $1.27 billion.
Rep. Elijah Cummings accused Mylan of using a "simple but
corrupt business model" to enrich themselves in the same
manner as Martin Shkreli of Turing Pharmaceuticals and
executives at Valeant Pharmaceuticals.
http://www.businessinsider.com/mylan-ceo-heather-bresch-house-oversight-
committee-hearing-epipen-2016-9
Perhaps the future problem for Mylan lies in the potential
actions the US Government may take to recover what it has
paid out to Mylan on flawed pricing figure.
